{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:14:48Z","timestamp":1776352488528,"version":"3.51.2"},"reference-count":84,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Commission","award":["JUST\/2013\/ISEC\/DRUGS\/AG\/6429"],"award-info":[{"award-number":["JUST\/2013\/ISEC\/DRUGS\/AG\/6429"]}]},{"name":"European Commission","award":["11.101336.3367"],"award-info":[{"award-number":["11.101336.3367"]}]},{"name":"University of Hertfordshire","award":["JUST\/2013\/ISEC\/DRUGS\/AG\/6429"],"award-info":[{"award-number":["JUST\/2013\/ISEC\/DRUGS\/AG\/6429"]}]},{"name":"University of Hertfordshire","award":["11.101336.3367"],"award-info":[{"award-number":["11.101336.3367"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Introduction: The designer benzodiazepine (DBZD) market continues to expand whilst evading regulatory controls. The widespread adoption of social media by pro-drug use communities encourages positive discussions around DBZD use\/misuse, driving demand. This research addresses the evolution of three popular DBZDs, etizolam (E), flubromazepam (F), and pyrazolam (P), available on the drug market for over a decade, comparing the quantitative chemical analyses of tablet samples, purchased from the internet prior to the implementation of the Psychoactive Substances Act UK 2016, with the thematic netnographic analyses of social media content. Method: Drug samples were purchased from the internet in early 2016. The characterisation of all drug batches were performed using UHPLC-MS and supported with 1H NMR. In addition, netnographic studies across the platforms X (formerly Twitter) and Reddit, between 2016\u20132023, were conducted. The latter was supported by both manual and artificial intelligence (AI)-driven thematic analyses, using numerous.ai and ChatGPT, of social media threads and discussions. Results: UHPLC-MS confirmed the expected drug in every sample, showing remarkable inter\/intra batch variability across all batches (E = 13.8 \u00b1 0.6 to 24.7 \u00b1 0.9 mg; F = 4.0 \u00b1 0.2 to 23.5 \u00b1 0.8 mg; P = 5.2 \u00b1 0.2 to 11.5 \u00b1 0.4 mg). 1H NMR could not confirm etizolam as a lone compound in any etizolam batch. Thematic analyses showed etizolam dominated social media discussions (59% of all posts), with 24.2% of posts involving sale\/purchase and 17.8% detailing new administration trends\/poly-drug use scenarios. Artificial intelligence confirmed three of the top five trends identified manually. Conclusions: Purity variability identified across all tested samples emphasises the increased potential health risks associated with DBZD consumption. We propose the global DBZD market is exacerbated by surface web social media discussions, recorded across X and Reddit. Despite the appearance of newer analogues, these three DBZDs remain prevalent and popularised. Reporting themes on harm\/effects and new developments in poly-drug use trends, demand for DBZDs continues to grow, despite their potent nature and potential risk to life. It is proposed that greater controls and constant live monitoring of social media user content is warranted to drive active regulation strategies and targeted, effective, harm reduction strategies.<\/jats:p>","DOI":"10.3390\/pharmacy12010013","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T07:47:16Z","timestamp":1705045636000},"page":"13","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6854-6171","authenticated-orcid":false,"given":"Anthony","family":"Mullin","sequence":"first","affiliation":[{"name":"Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit, University of Hertfordshire, Hatfield AL10 9AB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Scott","sequence":"additional","affiliation":[{"name":"Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit, University of Hertfordshire, Hatfield AL10 9AB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Vaccaro","sequence":"additional","affiliation":[{"name":"Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit, University of Hertfordshire, Hatfield AL10 9AB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0668-1260","authenticated-orcid":false,"given":"Giuseppe","family":"Floresta","sequence":"additional","affiliation":[{"name":"Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit, University of Hertfordshire, Hatfield AL10 9AB, UK"},{"name":"Department of Drug and Health Sciences, University of Catania, 95131 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8843-0595","authenticated-orcid":false,"given":"Davide","family":"Arillotta","sequence":"additional","affiliation":[{"name":"School of Clinical Pharmacology and Toxicology, University of Florence, 50121 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6338-8653","authenticated-orcid":false,"given":"Valeria","family":"Catalani","sequence":"additional","affiliation":[{"name":"Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit, University of Hertfordshire, Hatfield AL10 9AB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3849-817X","authenticated-orcid":false,"given":"John M.","family":"Corkery","sequence":"additional","affiliation":[{"name":"Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit, University of Hertfordshire, Hatfield AL10 9AB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8365-5894","authenticated-orcid":false,"given":"Jacqueline L.","family":"Stair","sequence":"additional","affiliation":[{"name":"Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit, University of Hertfordshire, Hatfield AL10 9AB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4178-5401","authenticated-orcid":false,"given":"Fabrizio","family":"Schifano","sequence":"additional","affiliation":[{"name":"Psychopharmacology, Drug Misuse & Novel Psychoactive Substances Research Unit, University of Hertfordshire, Hatfield AL10 9AB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8255-0660","authenticated-orcid":false,"given":"Amira","family":"Guirguis","sequence":"additional","affiliation":[{"name":"Pharmacy, Medical School, The Grove Extension, Swansea University, Swansea SA2 8PP, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"ref_1","unstructured":"EMCDDA (European Monitoriing Centre for Drugs and Drug Addiction) (2021). European Drug Report 2021: Trends and Developments, EMCDDA. Available online: https:\/\/www.emcdda.europa.eu\/publications\/edr\/trends-developments\/2021_en."},{"key":"ref_2","unstructured":"UNODC (2023, September 09). World Drug Report 2023. (United Nations Publication, 2023). Available online: https:\/\/www.unodc.org\/res\/WDR-2023\/WDR23_Exsum_fin_SP.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s11606-021-07035-6","article-title":"Benzodiazepine-involved overdose deaths in the USA: 2000\u20132019","volume":"37","author":"Kleinman","year":"2022","journal-title":"J. Gen. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e202361","DOI":"10.1001\/jamanetworkopen.2020.2361","article-title":"Alcohol or benzodiazepine co-involvement with opioid overdose deaths in the United States, 1999\u20132017","volume":"3","author":"Tori","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_5","unstructured":"National Records of Scotland (NRS) (2023, October 17). Drug-Related Deaths in Scotland in 2021, Available online: https:\/\/www.nrscotland.gov.uk\/files\/statistics\/drug-related-deaths\/21\/drug-related-deaths-21-report.pdf."},{"key":"ref_6","unstructured":"National Records of Scotland (NRS) (2023, October 17). Drug-Related Deaths in Scotland in 2022, Available online: https:\/\/www.nrscotland.gov.uk\/files\/\/statistics\/drug-related-deaths\/22\/drug-related-deaths-22-report.pdf."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1177\/02698811221104065","article-title":"Alprazolam-related deaths in Scotland, 2004\u20132020","volume":"36","author":"Corkery","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am. J. Prev. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1360-0443.1999.9479612.x","article-title":"Mechanisms of fatal opioid overdose","volume":"94","author":"White","year":"1999","journal-title":"Addiction"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: A review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"ref_11","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system\u2013mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/1570159X18666200110121333","article-title":"\u2018New\/Designer Benzodiazepines\u2019: An analysis of the literature and psychonauts\u2019 trip reports","volume":"18","author":"Orsolini","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"ref_13","unstructured":"Singer, J.A. (2019). Will US Drug Policymakers Blow It Again\u2014This Time with Benzodiazepines?, CATO Institute. Available online: https:\/\/www.cato.org\/blog\/will-us-drug-policymakers-blow-it-again-time-benzodiazepines."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/wps.20236","article-title":"Designer benzodiazepines: A new challenge","volume":"14","author":"Moosmann","year":"2015","journal-title":"World Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Di Trana, A., Berardinelli, D., Montanari, E., Berretta, P., Basile, G., Huestis, M.A., and Busard\u00f2, F.P. (2022). Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232314619"},{"key":"ref_16","unstructured":"EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) (2021). Timeline of Benzodiazepines Formally Notified to the EU Early Warning System for the First Time, 2007\u20132020, EMCDDA. Available online: www.emcdda.europa.eu."},{"key":"ref_17","unstructured":"Home Office (2016). Psychoactive Substance Act 2016, The Stationery Office Limited. Available online: http:\/\/services.parliament.uk\/bills\/2015-16\/psychoactivesubstances.html."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jat\/bkv122","article-title":"ELISA detection of phenazepam, etizolam, pyrazolam, flubromazepam, diclazepam and delorazepam in blood using Immunalysis\u00ae benzodiazepine kit","volume":"40","author":"Torrance","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jms.3279","article-title":"Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics","volume":"48","author":"Moosmann","year":"2013","journal-title":"J. Mass Spectrom."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11419-013-0187-4","article-title":"Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine","volume":"31","author":"Moosmann","year":"2013","journal-title":"Forensic Toxicol."},{"key":"ref_21","unstructured":"Schmid, M.G. (2018). Light in Forensic Science: Issues and Applications, Royal Society of Chemistry."},{"key":"ref_22","unstructured":"Home Office (2023, September 09). Review of the Psychoactive Act 2016, Available online: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/756896\/Review_of_the_Psychoactive_Substances_Act__2016___web_.pdf."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/eurpub\/ckac161","article-title":"Evidence of the emergence of illicit benzodiazepines from online drug forums","volume":"32","author":"Sarker","year":"2022","journal-title":"Eur. J. Public Health"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Arillotta, D., Guirguis, A., Corkery, J.M., Scherbaum, N., and Schifano, F. (2021). COVID-19 pandemic impact on substance misuse: A social media listening, mixed method analysis. Brain Sci., 11.","DOI":"10.3390\/brainsci11070907"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"632405","DOI":"10.3389\/fpsyt.2020.632405","article-title":"Identifying New\/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach","volume":"11","author":"Catalani","year":"2011","journal-title":"Front. Psychiatry"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.osnem.2018.11.001","article-title":"Where should one get news updates: X or Reddit","volume":"9","author":"Priya","year":"2019","journal-title":"Online Soc. Netw. Media"},{"key":"ref_27","unstructured":"Dean, B. (2023). Reddit Users and Growth Stats, BacklinKo. Available online: https:\/\/backlinko.com\/reddit-users."},{"key":"ref_28","unstructured":"Dean, B. (2023). How Many People Use Twitter in 2023, BacklinKo. Available online: https:\/\/backlinko.com\/twitter-users."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Seaman, I., and Giraud-Carrier, C. (2016, January 4\u20137). Prevalence and attitudes about illicit and prescription drugs on Twitter. Proceedings of the 2016 IEEE International Conference on Healthcare Informatics (ICHI), Chicago, IL, USA.","DOI":"10.1109\/ICHI.2016.98"},{"key":"ref_30","unstructured":"European Medicines Agency (EMA) (2023, October 17). ICH Harmonised Guideline: Validation of Analytical Procedures\u2014Q2(R2). Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-q2r2-validation-analytical-procedures-step-2b_en.pdf."},{"key":"ref_31","unstructured":"Food and Drug Administration (FDA) (2023, October 17). Analytical Procedures and Methods Validation for Drugs and Biologics, Available online: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/analytical-procedures-and-methods-validation-drugs-and-biologics."},{"key":"ref_32","unstructured":"(2023, August 25). X Fair Usage Policy. Available online: https:\/\/help.X.com\/en\/rules-and-policies\/fair-use-policy."},{"key":"ref_33","unstructured":"Reddit (2023, August 25). Reddit User Agreement. Available online: https:\/\/www.redditinc.com\/policies\/user-agreement."},{"key":"ref_34","unstructured":"Numerous.ai (2023, September 07). Numerous.ai Internet Analysis Tool. Available online: https:\/\/numerous.ai\/."},{"key":"ref_35","unstructured":"ChatGPT (2023, September 07). ChatGPT Internet Analysis Tool. Available online: https:\/\/openai.com\/chatgpt."},{"key":"ref_36","unstructured":"Wankhede, C. (2023, September 09). Does ChatGPT Have a Character Limit?. Available online: https:\/\/www.androidauthority.com\/chatgpt-character-limit-3292997\/."},{"key":"ref_37","unstructured":"Cayman Chemicals (2023, October 11). Etizolam Monograph. Available online: https:\/\/cdn.caymanchem.com\/cdn\/gcms\/12063-0480732-GCMS.pdf."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Mullin, A., Scott, M., Vaccaro, G., Gittins, R., Ferla, S., Schifano, F., and Guirguis, A. (2023). Handheld Raman Spectroscopy in the First UK Home Office Licensed Pharmacist-Led Community Drug Checking Service. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20064793"},{"key":"ref_39","unstructured":"Cayman Chemicals (2023, October 11). Flubromazepam Monograph. Available online: https:\/\/cdn.caymanchem.com\/cdn\/gcms\/15157-0570041-GCMS.pdf."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"110274","DOI":"10.1016\/j.forsciint.2020.110274","article-title":"Retrospective screening of synthetic cannabinoids, synthetic opioids and designer benzodiazepines in data files from forensic postmortem samples analysed by UHPLC-QTOF-MS from 2014 to 2018","volume":"311","author":"Gundersen","year":"2020","journal-title":"Forensic Sci. Int."},{"key":"ref_41","unstructured":"Cayman Chemicals (2023, October 11). Pyrazolam Monograph. Available online: https:\/\/cdn.caymanchem.com\/cdn\/gcms\/14901-0455692-GCMS.pdf."},{"key":"ref_42","unstructured":"SWGDRUG (2023, October 11). Etizolam. Available online: https:\/\/www.swgdrug.org\/Monographs\/Etizolam.pdf."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"10280","DOI":"10.1021\/acs.joc.9b01433","article-title":"Synthesis of Flubromazepam Positional Isomers for Forensic Analysis","volume":"84","author":"Ligon","year":"2019","journal-title":"J. Org. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s13181-018-0659-3","article-title":"Assessment of the availability, cost, and motivations for use over time of the new psychoactive substances\u2014Benzodiazepines diclazepam, flubromazepam, and pyrazolam\u2014In the UK","volume":"14","author":"Abouchedid","year":"2018","journal-title":"J. Med. Toxicol."},{"key":"ref_45","unstructured":"EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) (2023, October 09). European Legal Database on Drugs. Available online: http:\/\/www.emcdda.europa.eu\/eldd."},{"key":"ref_46","unstructured":"EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) (2021). 2021a (2021) New benzodiazepines in Europe\u2014A review, EMCDDA. Available online: https:\/\/www.emcdda.europa.eu\/publications\/rapid-communications\/new-benzodiazepines-europe-review_en."},{"key":"ref_47","unstructured":"ACMD (Advisory Council on the Misuse of Drugs) (2023, October 11). Novel Benzodiazepines. A Review of Evidence of Use and Harms of Novel Benzodiazepines, Available online: https:\/\/assets.publishing.service.gov.uk\/media\/5ea95a1cd3bf7f6523c81c01\/ACMD_report_-_a_review_of_the_evidence_of_use_and_harms_of_novel_benzodiazepines.pdf."},{"key":"ref_48","unstructured":"UNODC Laboratory and Scientific Service Portals (2023, December 06). Twelve Substances and One Precursor \u201cScheduled\u201d at the 63rd Session of the Commission on Narcotic Drugs. Available online: https:\/\/www.unodc.org\/LSS\/Announcement\/Details\/165b82de-e7ef-4a92-8614-9f8ad4819083."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00280074","article-title":"Single and multiple dose pharmacokinetics of etizolam in healthy subjects","volume":"40","author":"Fracasso","year":"1991","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_50","unstructured":"DGHSC (Director General Health and Social Care) (2023, October 11). Benzodiazepine Use\u2014Current Trends: Evidence Review, Available online: https:\/\/www.gov.scot\/publications\/evidence-review-current-trends-benzodiazepine-use-scotland\/pages\/3\/."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1021\/jo01058a010","article-title":"Quinazolines and 1,4-Benzodiazepines. VI.1a Halo-, Methyl-, and Methoxy-substituted 1,3-Dihydro-5-phenyl-2H-1,4-benzodiazepin-2-ones1b,c","volume":"27","author":"Sternbach","year":"1962","journal-title":"J. Org. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Stahl, S.M. (2021). Stahl\u2019s Essential Psychopharmacology. Neuroscientific Basis and Practical Applications, Cambridge University Press. [5th ed.].","DOI":"10.1017\/9781108975292"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/neurolint14030053","article-title":"Novel designer benzodiazepines: Comprehensive review of evolving clinical and adverse effects","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurol. Int."},{"key":"ref_54","unstructured":"SpectraBase (2023, October 11). Etizolam. Available online: https:\/\/spectrabase.com\/compound\/FXsiIsWI1Tn."},{"key":"ref_55","unstructured":"SWGDRUG (2023, October 11). Flubromazepam. Available online: https:\/\/www.swgdrug.org\/Monographs\/Flubromazepam.pdf."},{"key":"ref_56","unstructured":"SpectraBase (2023, October 11). Flubromazepam. Available online: https:\/\/spectrabase.com\/compound\/6ohTApdCf."},{"key":"ref_57","unstructured":"PubChem (2023, October 11). Pyrazolam, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Pyrazolam#section=FTIR-Spectra."},{"key":"ref_58","unstructured":"SpectraBase (2023, October 11). Pyrazolam. Available online: https:\/\/spectrabase.com\/compound\/DtfWZ5VhSzm."},{"key":"ref_59","unstructured":"Statistica (2023, October 11). Social Media Use During COVID-19 World-Wide\u2014Statistics & Facts. Available online: https:\/\/www.statista.com\/topics\/7863\/social-media-use-during-coronavirus-covid-19-worldwide\/#topicOverview."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.psym.2019.02.007","article-title":"Novel ways to acquire designer benzodiazepines: A case report and discussion of the changing role of the internet","volume":"60","author":"Shapiro","year":"2019","journal-title":"Psychosomatics"},{"key":"ref_61","first-page":"75","article-title":"Internet pharmacies and online prescription drug sales: A cross-sectional study","volume":"12","author":"Littlejohn","year":"2005","journal-title":"Drugs: Educ. Prev. Policy"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.2196\/jmir.6426","article-title":"Scaling up research on drug abuse and addiction through social media big data","volume":"19","author":"Kim","year":"2017","journal-title":"J. Med. Internet Res."},{"key":"ref_63","first-page":"867","article-title":"Social media-based analysis of opioid epidemic using Reddit","volume":"Volume 2018","author":"Pandrekar","year":"2018","journal-title":"AMIA Annual Symposium Proceedings"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40264-015-0379-4","article-title":"Social media mining for toxicovigilance: Automatic monitoring of prescription medication abuse from Twitter","volume":"39","author":"Sarker","year":"2016","journal-title":"Drug Saf."},{"key":"ref_65","unstructured":"EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) (2021). Drug-Related Deaths and Mortality in Europe, EMCDDA. Available online: https:\/\/www.emcdda.europa.eu\/publications\/meeting-reports-and-conference-proceedings\/drug-related-deaths-and-mortality-europe_en."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.forsciint.2017.01.027","article-title":"Identification of new psychoactive substances (NPS) using handheld Raman spectroscopy employing both 785 and 1064 nm laser sources","volume":"273","author":"Guirguis","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"ref_67","unstructured":"McAuley, A. (2018). The Role of Etizolam in Scottish Drug-Related Deaths, Glasgow Caledonian University. Available online: https:\/\/www.emcdda.europa.eu\/system\/files\/attachments\/12056\/3.2%20Andy%20McAuley_DRD_NPS%20Benzo.pptx.pdf."},{"key":"ref_68","unstructured":"WEDINOS (Welsh Emerging Drugs & Identification of Novel Substances) (2023, October 12). Annual Report April 2022\u2013March 2023. Available online: https:\/\/www.wedinos.org\/resources\/downloads\/Annual-Report-22-23-English.pdf."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Peppin, J., Pergolizzi, J.V., Raffa, R.B., and Wright, S.L. (2020). The Benzodiazepines Crisis, Oxford University Press. Online ISBN 9780197517307, Print ISBN 9780197517277.","DOI":"10.1093\/med\/9780197517277.001.0001"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1093\/jat\/bkaa146","article-title":"A case series of etizolam in opioid-related deaths","volume":"45","author":"Gevorkyan","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"103169","DOI":"10.1016\/j.drugpo.2021.103169","article-title":"An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods","volume":"93","author":"Laing","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/jat\/bkad036","article-title":"Increasing Prevalence of Designer Benzodiazepines in Impaired Driving; a 5 Year Analysis from 2017\u20132021","volume":"47","author":"Papsun","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"ref_73","unstructured":"National Records of Scotland (NRS) (2023, December 06). Drug-Related Deaths in Scotland in 2020, Available online: https:\/\/www.nrscotland.gov.uk\/statistics-and-data\/statistics\/statistics-by-theme\/vital-events\/deaths\/drug-related-deaths-in-scotland\/2020."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.forsciint.2019.05.018","article-title":"Is etizolam a safe medication? Effects on psychomotor perfomance at therapeutic dosages of a newly abused psychoactive substance","volume":"301","author":"Montanari","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"ref_75","unstructured":"National Records of Scotland (NRS) (2023, October 17). Drug-Related Deaths in Scotland in 2019, Available online: https:\/\/www.nrscotland.gov.uk\/statistics-and-data\/statistics\/statistics-by-theme\/vital-events\/deaths\/drug-related-deaths-in-scotland\/2019."},{"key":"ref_76","unstructured":"WEDINOS (Welsh Emerging Drugs & Identification of Novel Substances) (2023, October 12). Annual Report April 2019\u2013March 2020. Available online: https:\/\/www.wedinos.org\/resources\/downloads\/WEDINOS-results-161220.pdf."},{"key":"ref_77","unstructured":"Dikeos, D., Theleritis, C.G., and Soldatos, C.R. (2008). Sleep Disorders: Diagnosis and Therapeutics, CRC Press. [1st ed.]. Chapter 10."},{"key":"ref_78","unstructured":"WEDINOS (Welsh Emerging Drugs & Identification of Novel Substances) (2023, October 12). Annual Report April 2021\u2013March 2022. Available online: https:\/\/www.wedinos.org\/resources\/downloads\/Annual-Report-21-22-English.pdf."},{"key":"ref_79","unstructured":"Reddit (2023, October 12). Flubromazepam vs. Flubromazolam. Available online: https:\/\/www.reddit.com\/r\/researchchemicals\/comments\/4ifzlb\/flubromazepam_vs_flubromazolam\/."},{"key":"ref_80","unstructured":"Reddit (2023, October 12). Flubromazepam vs. Flubromazolam. Available online: https:\/\/www.reddit.com\/r\/researchchemicals\/comments\/vxei0l\/popular_rc_benzo_pyrazolam_dangerously_wrong_dose\/."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Marland, V., Reid, R., Brandon, A., Hill, K., Cruickshanks, F., McKenzie, C., Norman, C., Nic Da\u00e9id, N., and Menard, H. (2023). Changing trends in novel benzodiazepine use within Scottish prisons: Detection, quantitation, prevalence, and modes of use. Drug Test. Anal.","DOI":"10.1002\/dta.3560"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Rousis, N., Li, Z., Bade, R., McLachlan, M., Mueller, J., O\u2019Brien, J., Samanipour, S., Tscharke, B., Thomaidis, N., and Thomas, K. (2023, December 06). Socioeconomic Status and Public Health in Australia: A Wastewater-Based Study. Environment International. Available online: https:\/\/api.semanticscholar.org\/CorpusID:251121788.","DOI":"10.1016\/j.envint.2022.107436"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00228-018-2550-1","article-title":"Presentations to the emergency department with non-medical use of benzodiazepines and Z-drugs: Profiling and relation to sales data","volume":"75","author":"Lyphout","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1590\/1413-812320202511.09632019","article-title":"Information about benzodiazepines: What does the internet offer us?","volume":"25","author":"Ramos","year":"2020","journal-title":"Ci\u00eancia Sa\u00fade Coletiva"}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/12\/1\/13\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:45:30Z","timestamp":1760103930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/12\/1\/13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["pharmacy12010013"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy12010013","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]}}}